One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The source summary mentions an after-dialysis dose; the source package-insert paragraph says both during and at the end of dialysis. Both statements are retained and require product-specific reconciliation.
The conventional renal table cannot be transferred to XR, and clavulanate content differs among formulations.
What to reconcile: Match both component strengths and formulation before using any table.
Open this note and its source referencesMatch both component strengths and formulation; compare dialysis instructions as a whole protocol.
Dialysis evidence: A regimen is reported in selected content
The selected conventional-product renal paragraph excludes the 875 mg dose when GFR is below 30 mL/min.
| GFR / treatment | Selected dose expressed by amoxicillin component |
|---|---|
| 10-30 mL/min | 250 or 500 mg every 12 hours, according to infection severity |
| Below 10 mL/min | 250 or 500 mg every 24 hours, according to infection severity |
| Hemodialysis | 250 or 500 mg every 24 hours; additional dose both during and at the end of dialysis |
The adult 250 mg tablet and 250 mg chewable tablet have different clavulanate amounts. These instructions are not an AUGMENTIN XR or ES-600 conversion. Confirm the complete component strength, not amoxicillin milligrams alone.
RDM61-rxlist-amoxicillinclav-0a71e46ff2-C1 · Source locator: Dosage and Administration: renal impairment; named precautions
No new official-label card was obtained for this product in v6.1. Earlier source layers, if present, were retained but not rechecked.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=amoxicillinclav&s1=RDM61-rxlist-amoxicillinclav-0a71e46ff2&h1=9353a22915a7b5df4b47cc6b5d9c13c9322b5c49c6b7fb4834e90fcd3edc1266